Oregon Health and Science University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Oregon Health and Science University sits in the top decile of US sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count).
Oregon Health and Science University: 546 sponsored US clinical trials, 91 recruiting.
Oregon Health and Science University sponsors 546 registered US clinical trials on ClinicalTrials.gov, 91 of them currently recruiting, and 370 completed. 73 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Oregon Health and Science University ranks in the top decile of sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
370 of 420 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
546 total, page 3 of 11
Success & Health Impacts For Transit Drivers During Onboarding
NCT03730792
BM-MNCs for Lower Extremity Compartment Syndrome Injury
NCT03880656
Readiness Supportive Leadership Training
NCT04152824
Oxytocin Receptor Expression in Pregnancy
NCT03907735
Validation of Sleep Questionnaires in the Down Syndrome Population
NCT03771469
Body Weight, Sleep, and Heart Health
NCT03388788
Wearable Suicidal Early Warning System for Adolescents
NCT03030924
WF and PR OCTA in Diabetic Retinopathy
NCT03922932
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)
NCT02968212
OCT Biomarkers for Diabetic Retinopathy
NCT02330042
A Kinder Coaching Program With Community Health Workers "READY"
NCT07677618
Precision T1D Platform - New Therapies for Cardio-Renal Complications
NCT07594145
Empowering Cardiovascular Health in Custodial Grandparents
NCT07083895
A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
NCT07293728
Postural Motor Activation Deficits After mTBI; Translating Laboratory Findings to Clinical Care
NCT07549529
Assessing Construction Execution Under Sleep Impairment
NCT07431970
Cefotetan Therapy for Escherichia Coli Infections
NCT07318584
App-Based Certified Diabetes Education Therapy (AB-CDE)
NCT07282639
Reentry Incentives and Support for Engagement With Contingency Management
NCT07322588
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
NCT06988319
Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness
NCT07356986
Rocklatan Retinal Perfusion OCT Study
NCT07174401
Opt-In Early Pilot Study
NCT06908187
Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia
NCT06946576
A Prospective Cohort Study to Evaluate the Safety, Efficacy, and Usability of the EpiZact Device
NCT06729255
Steroids After Spine Fusion Surgery
NCT04568837
Time-Restricted Eating in Huntington's Disease: A Clinical Pilot Study
NCT06490367
Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide
NCT06422325
Metformin Use in Patients Undergoing Total Joint Replacement Surgery
NCT06280274
Ashwagandha Pharmacokinetics Study in Older Adults
NCT06171724
Center M: Digital Health Innovation Pilot
NCT06000449
Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects
NCT06000423
Treating Respiratory Emergencies in Children Study
NCT06074185
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
NCT04901325
The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA)
NCT06072859
Influence of Yogic Breathwork on Sleep
NCT05756686
Postoperative Active Recovery
NCT05950633
DailyDose Smart Snack Study for T1D on MDI
NCT05967260
Feasibility and Acceptability of Stress Induction, Physiological Data Collection, and Mindfulness-Based Stress Reduction Among Combat Veterans With PTSD
NCT05938816
Advanced Provision of Care
NCT05848908
Two Way Crossover Closed Loop MPC vs Control IQ
NCT05799781
Neighborhood-based Physical and Social Activity for Older Black Caregivers and People Living With Dementia
NCT05658328
Sleep Management And Recovery After Traumatic Brain Injury in Kids: Pilot Intervention of Melatonin
NCT04932096
Pilot Study of an Advance Care Planning Intervention Among Persons With Dementia
NCT05049291
Dosimeter Location in Pain Physicians
NCT06309407
Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders
NCT05411835
Feasibility and Acceptability of Powdered Multinutrient Formula
NCT05234593
Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit
NCT04468919
Advance Care Planning (ACP) in Primary Care for Dementia
NCT05322317
Sleep After Pediatric Critical Illness
NCT05879640
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 52 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Oregon Health and Science University pipeline
91 recruiting of 546 indexed (17% open); 370 completed (68%).
Phase mix: 73 late (III/IV) vs 92 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Oregon Health and Science University: open-pipeline peers nationwide
Peers matched on 546 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Oregon Health and Science University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 546 trials (± recruiting share)
- Ohio State University · 552 trials · 21% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Oregon Health and Science University page
546 registered trials is a research-attention snapshot, not an endorsement of Oregon Health and Science University or any single study.
- 91 of Oregon Health and Science University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Oregon Health and Science University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Oregon Health and Science University pipeline card: 546 registered trials from official public datasets.Report a data error.